What is QuantuMDx Group?
QuantuMDx Group is a medical technology firm specializing in advanced diagnostic solutions. Their core offering, the Q-POC platform, is designed to deliver rapid and accurate diagnostic results in approximately 30 minutes, making high-quality testing more accessible in various healthcare settings. The company targets testing providers, laboratory professionals, and clinical managers, aiming to improve patient care through enhanced diagnostic capabilities. The company's focus on point-of-care diagnostics positions it within a growing market driven by the need for faster, more localized medical testing.
How much funding has QuantuMDx Group raised?
QuantuMDx Group has raised a total of $39.6M across 5 funding rounds:
Grant
$1.6M
Unspecified
$8.4M
Private Equity
$2.5M
Unspecified
$12M
Debt
$15.1M
Grant (2013): $1.6M, investors not publicly disclosed
Unspecified (2014): $8.4M, investors not publicly disclosed
Private Equity (2016): $2.5M supported by Helsinn Investment Fund
Unspecified (2018): $12M, investors not publicly disclosed
Debt (2021): $15.1M, investors not publicly disclosed
Key Investors in QuantuMDx Group
Helsinn Investment Fund
The Helsinn Investment Fund, owned by the Helsinn Group, focuses on early-stage investments in areas with high unmet patient needs, leveraging 40 years of R&D and commercialization expertise. They support companies with innovative technologies in cancer therapeutics and diagnostics, supportive care, metabolic and gastrointestinal disorders, and dermatology.
What's next for QuantuMDx Group?
The recent major strategic investment in QuantuMDx Group signals a pivotal moment for the company, likely enabling accelerated scaling of its Q-POC platform and further research and development into new diagnostic applications. This capital infusion is expected to bolster its market penetration and solidify its position as a key player in the point-of-care diagnostics industry. The company's trajectory suggests a focus on expanding its global reach and enhancing its product pipeline to address diverse healthcare needs.
See full QuantuMDx Group company page
